Given that the over-activation of GSK3β has been linked to tau aggregation into paired helical filaments (PHFs) and neurofibrillary tangles (NFTs) [179], the inhibition of GSK3β by curcumin would hinder both Aβ production and tau aggregation, two crucial events in AD pathogenesis. The gene discussed is MAPT; the disease is Alzheimer disease.